Click Here to read more about the impact of the Omicron variant of SARS-CoV-2 on BTNX’s Rapid Response® COVID-19 Antigen Rapid Tests
The Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset and from individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection, when tested twice over two (or three) days with at least 24 hours (and no more than 36 hours) between tests.
Results of the Rapid Response COVID-19 Antigen Rapid Test can be read at 15 minutes. Results should be read at 15 minutes, but not later than 30 minutes. If any lines show up after 30 minutes, they should not be considered as true results.
The colour intensity of the lines on your test may vary depending on the concentration of analytes present in the specimen. Therefore, any shade of colour in the test region should be considered positive. Results should be interpreted at 15 minutes. Results should not be interpreted after 30.
The test must be stored between 2-30°C. All components must be brought to room temperature (15-30°C) before conducting the test.
No, the test must be used in room temperature conditions (15~30°C).
Yes, you may still use the test, bring the test indoors and allow all kit contents to reach room temperature, by waiting for a minimum of 30 minutes. The Rapid Response COVID-19 Rapid Antigen Test has been tested for extreme shipping conditions and its performance has not been impacted.
MHCare Medical offers protection and infection control products for schools, doctors, dentists, hospitals, long term care homes and other medical professionals. Contact us today to learn more.
*This article is not meant to be taken as medical advice. Please follow the advice of your local health authorities when making decisions about your own health and the people around you.